Several enzymes can be used as a target for COVID-19 therapeutics including PI3K ̧ mTOR, growth factor receptor, RAF, MAP2K2, FLT3, AXL, AKT, and matrix metalloprotease MMP2 and MMP9. The gene discussed is FLT3; the disease is COVID-19.